Therapeutic Drug Monitoring Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the therapeutic drug monitoring industry. The report analyzes and declares the historical and current trends analysis of the therapeutic drug monitoring industry and subsequently recommends the projected trends anticipated to be observed in the therapeutic drug monitoring market during the upcoming years.

The therapeutic drug monitoring market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire therapeutic drug monitoring market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volumes (Units) and value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the therapeutic drug monitoring industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the therapeutic drug monitoring industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the therapeutic drug monitoring market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders the therapeutic drug monitoring involved in the entire value chain of the therapeutic drug monitoring industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the therapeutic drug monitoring sector. Key strategic developments in the therapeutic drug monitoring market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the therapeutic drug monitoring market are appropriately highlighted in the report.

Report Scope

The therapeutic drug monitoring market research report delivers an acute valuation and taxonomy of the therapeutic drug monitoring industry by practically splitting the market on the basis of different components, applications, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the therapeutic drug monitoring industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the therapeutic drug monitoring industry is provided for the leading economies of the world.

The global therapeutic drug monitoring industry is anticipated to provide budding opportunities to the manufacturers, vendors, and customers across the globe. The sudden rise of the COVID-19 pandemic level has a positive impact on the demand patterns of the therapeutic drug monitoring which is expected to propel the growth of the global market in the next 10 years. Additionally, increasing the use of TDM in traditional anticancer therapies, coupled with the growing number of organ transplant procedures across the globe are factors driving the growth of the global market. However, the reluctance of small hospitals to offer TDM services is a factor expected to hinder the growth of the global market in the near future.

The global therapeutic drug monitoring market is segmented on the basis of product, class of drug, technology, and end-user. On the basis of product type, the global market is categorized into consumables and equipment. Based on technology the global market is bifurcated into immunoassays, colorimetric immunoassays, radioimmunoassays, other immunoassays, and chromatography-MS. The global market is segmented into antiepileptic drugs, antiarrhythmic drugs, immunosuppressant drugs, antibiotic drugs, bronchodilator drugs, psychoactive drugs, and other drug classes, depending upon the class of the drugs. Also, the end-users in the global market include hospital laboratories, commercial/private laboratories, and other end users.

Some of the essential players operating in the therapeutic drug monitoring market, but not restricted to include

• Abbott Laboratories
• Danaher Corporation
• Biomérieux
• Bühlmann Laboratories
• Randox Laboratories Hoffmann-La Roche
• Siemens Healthineers
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Sekisui Medical.

Major companies in the global therapeutic drug monitoring market are trying to focus on the inorganic business strategies including launches of innovative products along with strategic partnerships.

The taxonomy of the therapeutic drug monitoring market industry by its scope and segmentation is as follows:

By Product

• Consumables
• Equipment
  • Immunoassay analyzers
  • Chromatography and MS detectors
  • Clinical chemistry analyzers

By Technology

• Immunoassays
  • Chemiluminescent immunoassays
  • Fluorescence immunoassays
• Colorimetric Immunoassays
• Radioimmunoassays
• Other immunoassays
• Chromatography-MS
  • Liquid Chromatography/Mass Spectrometry
  • Gas Chromatography-Mass Spectrometry

By Class of Drug

• Antiepileptic drugs
• Antiarrhythmic drugs
• Immunosuppressant drugs
• Antibiotic drugs
• Bronchodilator drugs
• Psychoactive drugs
• Other drug classes

By End User

• Hospital laboratories
• Commercial/private laboratories
• Other end users

Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa